However, treatment of HCC tissues with the combination therapy led to higher expression of ZNF225; the combination therapy also led to downregulation of LC3B, as well as upregulation of p62, suggesting autophagy reduction. Here, ZNF225 is linked to hepatocellular carcinoma.